{"database": "lobbying", "table": "lobbying_activities", "rows": [[3327589, "7b1576d0-75c9-4f8e-9ea1-304ed8d44cae", "1T", "THORN RUN PARTNERS", 400534596, "BRIDGEBIO PHARMA, INC.", 2025, "first_quarter", "MMM", "Issues related to the treatment of rare diseases.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 1, "2025-03-13T13:39:46-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3327589"], "units": {}, "query_ms": 44.15442800382152, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}